NYSE - Delayed Quote • USD Agilent Technologies, Inc. (A) Follow Add holdings 116.74 +0.94 +(0.81%) At close: June 9 at 4:00:02 PM EDT 117.85 +1.11 +(0.95%) Pre-Market: 5:46:49 AM EDT All News Press Releases SEC Filings Spotting Winners: Bio-Techne (NASDAQ:TECH) And Research Tools & Consumables Stocks In Q1 Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bio-Techne (NASDAQ:TECH) and the best and worst performers in the research tools & consumables industry. Don't Overlook Agilent (A) International Revenue Trends While Assessing the Stock Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects. Agilent Technologies Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags Agilent Technologies ( NYSE:A ) Second Quarter 2025 Results Key Financial Results Revenue: US$1.67b (up 6.0% from 2Q... Company News for May 30, 2025 Companies in The News Are: A, VEEV, HPQ, BMA These Stocks Moved the Most Today: Nvidia, Salesforce, HP Inc., Tesla, C3.ai, e.l.f. Beauty, Veeva, SentinelOne, Best Buy, and More Nvidia’s first-quarter earnings top Wall Street estimates as data-center revenue surges 73%, and Tesla rises as CEO Elon Musk ends his work for the Trump administration. Agilent Technologies (NYSE:A) Revises Full-Year Revenue Guidance, Reports Q2 Earnings and Growth Agilent Technologies (NYSE:A) recently announced updates regarding its corporate guidance for Q3 2025 and raised its full-year earnings outlook, amidst reporting a 3.75% share price increase over the past month. Despite a decline in net income and earnings per share in Q2, the company's strong sales growth and revenue guidance adjustment likely provided support for investor sentiment. Concurrently, the broader market has been showing a mixed performance due to macroeconomic factors such as... Agilent Q2 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise A's second-quarter fiscal 2025 results benefit from strong LC & services, but margin contraction raises investor concerns. Agilent Braces For Potential US-EU Tariff Hike, Maintains Annual Outlook Agilent Technologies Inc. (NYSE:A) reported second-quarter 2025 sales of $1.67 billion on Wednesday, almost in line with the consensus of $1.63 billion, representing growth of 6% reported and up 5.3% core year-over-year. The Life Sciences and Diagnostics Markets Group (LDG) reported second-quarter revenue of $654 million, an increase of 8% reported and 3% core year-over-year. LDG’s operating margin for the quarter was 19.7%. The Agilent CrossLab Group (ACG) reported second-quarter revenue of $71 A Q2 Earnings Call: Mixed Revenue Performance, Margin Pressure, and Strategic Updates Life sciences tools company Agilent Technologies (NYSE:A) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 6% year on year to $1.67 billion. Its non-GAAP EPS of $1.31 per share was 3.6% above analysts’ consensus estimates. Zacks Industry Outlook Highlights AMETEK, Itron and Cognex AMETEK, Itron and Cognex gain from 5G and automation tailwinds despite macro headwinds weighing on the electronics testing industry. Agilent Technologies Inc (A) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... Agilent Technologies Inc (A) reports a 6% revenue increase and a 7% EPS growth, navigating tariff impacts with strategic mitigation. Agilent Stock Gains as Earnings Surprise Despite Research Funding Cuts Rivals of the lab tools and testing company have been buffeted by the Trump administration’s disruptions to funding to U.S. academic labs. Here's What Key Metrics Tell Us About Agilent (A) Q2 Earnings While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended April 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. Agilent Technologies (A) Q2 Earnings and Revenues Top Estimates Agilent (A) delivered earnings and revenue surprises of 3.97% and 2.64%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock? Life sciences firm Agilent beats quarterly estimates on instrument demand The company also raised its annual revenue forecast to be between $6.73 billion and $6.81 billion, compared to its prior expectations of $6.68 billion to $6.76 billion. Life sciences firms like Agilent have seen weak order levels in the past two years due to reduced spending from biotech clients, and investors have expressed concerns that the difficulties, initially expected to ease this year, may persist due to policy uncertainties from the Trump administration. "The Agilent team delivered strong second-quarter results in a highly dynamic market environment,” said President and CEO Padraig McDonnell. Agilent (NYSE:A) Beats Q1 Sales Targets, Stock Soars Life sciences tools company Agilent Technologies (NYSE:A) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 6% year on year to $1.67 billion. Guidance for next quarter’s revenue was better than expected at $1.66 billion at the midpoint, 0.9% above analysts’ estimates. Its non-GAAP profit of $1.31 per share was 3.6% above analysts’ consensus estimates. Agilent: Fiscal Q2 Earnings Snapshot The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $1.26 per share. The scientific instrument maker posted revenue of $1.67 billion in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $1.63 billion. Agilent Reports Second-Quarter Fiscal Year 2025 Financial Results SANTA CLARA, Calif., May 28, 2025--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.67 billion for the second quarter ended April 30, 2025, representing growth of 6.0% reported and up 5.3% core(1) compared with the second quarter of 2024. Agilent Names August Specht as Chief Technology Officer SANTA CLARA, Calif., May 28, 2025--Agilent Technologies Inc. (NYSE: A) today announced August Specht, Ph.D., has been named the company’s Chief Technology Officer. Specht, previously vice president of Global R&D for the Chromatography and Mass Spectrometry Division at Thermo Fisher Scientific, will join Agilent on June 9. Agilent Announces the Enhanced 8850 Gas Chromatograph: Compact, Powerful, and Now Mass Spec-Connected for Superior Analytical Performance SANTA CLARA, Calif., May 27, 2025--Agilent Technologies Inc. (NYSE: A) today announced the latest enhancements to the Agilent 8850 Gas Chromatograph (GC), including compatibility with single and triple quadrupole mass spectrometry (MS) systems and related tools and technologies to improve laboratory productivity. The unique design and compact size of the 8850 GC make it one of the fastest and smallest benchtop GC/MS available. It is explicitly designed for labs that require high speed and high p Performance Overview Trailing total returns as of 6/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) Return A S&P 500 (^GSPC) YTD -12.92% +2.11% 1-Year -11.56% +12.32% 3-Year -3.94% +49.48%